Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 401 participants.
Also called NCT01165684
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 401 participants
- Sponsor
- Registry
-
NCT01165684 -
2010-018974-19
-
- Main results
- Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Brazil, Canada, France, North Macedonia, Slovenia
- Registry status
- Completed
Technical summary
Registry record NCT01165684. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-04 (actual). Results posted on 2013-06-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen
- Acronym
- Full STEP™
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- insulin aspart
- Intervention (Drug)
- insulin aspart
- Intervention (Drug)
- insulin detemir
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01165684- Content hash
a1736e0ff726d1c5255e5e662724f63c47fa27d8adbc4b02e1d74529c2c87ae1